Registration of securities issued in business combination transactions

Consolidated Statements of Changes in Stockholders??? Equity (Deficit)

v3.23.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Series A
Convertible Redeemable Preferred Stock
Series B
Convertible Redeemable Preferred Stock
Special Voting Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2020 $ 20,405,219 $ 100 $ 94,088,323 $ (91,497) $ (57,179,525) $ 57,222,620
Balance (in Shares) at Dec. 31, 2020 2,667,349 995,062        
Conversion of exchangeable shares to common stock     $ (18,039,181) $ 12 18,039,169      
Conversion of exchangeable shares to common stock (in Shares)     (2,358,063) 117,903        
Settlement of convertible notes       $ 15 11,610,571     11,610,586
Settlement of convertible notes (in Shares)       154,706        
Shares withheld for withholding taxes       $ (1) (520,394)     (520,395)
Shares withheld for withholding taxes (in Shares)       (6,089)        
Shares issued in connection with Viridian acquisition       $ 5 6,187,995     6,188,000
Shares issued in connection with Viridian acquisition (in Shares)       51,550        
Shares issued in connection with asset purchase         300,000     300,000
Shares issued in connection with asset purchase (in Shares)       4,167        
Shares issued (returned) in connection with 365 Cannabis acquisition       $ 18 11,996,043     11,996,061
Shares issued (returned) in connection with 365 Cannabis acquisition (in Shares)       178,572        
Stock-based compensation         2,070,358     2,070,358
Shares issued in connection with the ATM offering program       $ 3 1,828,116     1,828,119
Shares issued in connection with the ATM offering program (in Shares)       27,819        
Settlement of liabilities with shares       $ 1 430,024     430,025
Settlement of liabilities with shares (in Shares)       5,085        
Restricted stock vesting       $ 2 (2)      
Restricted stock vesting (in Shares)       21,386        
Forfeitures of restricted shares (in Shares)       (67)        
Foreign currency translation adjustments           53,020   53,020
Unrealized gains on convertible notes           100,000   100,000
Net loss             (31,328,711) (31,328,711)
Balance at Dec. 31, 2021 $ 2,366,038 $ 155 146,030,203 61,523 (88,508,236) 59,949,683
Balance (in Shares) at Dec. 31, 2021 309,286 1,550,094        
Conversion of exchangeable shares to common stock     $ (180,647)   180,647      
Conversion of exchangeable shares to common stock (in Shares)     (23,614) 1,180        
Settlement of convertible notes       $ 21 3,925,479     3,925,500
Settlement of convertible notes (in Shares)       207,427        
Shares withheld for withholding taxes         (9,926)     (9,926)
Shares withheld for withholding taxes (in Shares)       (1,662)        
Shares issued (returned) in connection with 365 Cannabis acquisition       $ (1) (939,999)     (940,000)
Shares issued (returned) in connection with 365 Cannabis acquisition (in Shares)       (13,988)        
Common shares and warrants issued in connection with unit offering, net of issue costs       $ 217 9,178,744     9,178,961
Common shares and warrants issued in connection with unit offering, net of issue costs (in Shares)       2,173,913        
Stock-based compensation         843,693     843,693
Shares issued in connection with the ATM offering program       $ 64 1,854,501     1,854,565
Shares issued in connection with the ATM offering program (in Shares)       642,956        
Issuance of convertible redeemable preferred stock, net of issue costs $ 3,435,600 $ 858,900            
Issuance of convertible redeemable preferred stock, net of issue costs (in Shares) 400,000 100,000            
Deemed dividends related to convertible redeemable preferred stock $ 764,400 $ 191,100     (955,500)     (955,500)
Redemption of convertible redeemable preferred stock $ (4,200,000) $ (1,050,000)            
Redemption of convertible redeemable preferred stock (in Shares) (400,000) (100,000)            
Settlement of liabilities with shares         49,529     49,529
Settlement of liabilities with shares (in Shares)       2,196        
Restricted stock vesting       $ 2 49,998     50,000
Restricted stock vesting (in Shares)       20,282        
Fractional share adjustment from stock split       $ 2 (2)      
Fractional share adjustment from stock split (in Shares)       20,382        
Foreign currency translation adjustments           40,577   40,577
Unrealized gains on convertible notes           245,000   245,000
Net loss             (79,057,610) (79,057,610)
Balance at Dec. 31, 2022 $ 2,185,391 $ 460 $ 160,207,367 $ 347,100 $ (167,565,846) $ (4,825,528)
Balance (in Shares) at Dec. 31, 2022 285,672 4,602,780